Angene

 

Angene is pledged to providing quality chemicals for use in research and development and commercial manufacturing. Angenes offers over 100,000 products including lab reagents, Building blocks,intermediates, bulk commodities, agro-chemicals, natural ingredients and active pharmaceutical ingredients (APIs). In addition to the 100,000+ products, Angene offers custom synthesis of chemicals that are not commercially available.

 

 
 
 
 
SARS-CoV-2 - Deferoxamine - Therapeutic Candidates

SARS-CoV-2 - Deferoxamine - Therapeutic Candidates


Deferoxamine (or Desferal) is a linear bacterial siderophore and chelating agent for trivalent cations. Deferoxamine is capable of binding free iron from plasma or cells to form the ferrioxamine complex. Due to its properties, deferoxamine is used as a first-line treatment for iron overload. Desferal is prescribed for various pathologies such as primary hemochromatosis, secondary hemosiderosis, acute martial intoxication, aluminum poisoning.
Deferoxamine has been included in some clinical studies to develop a treatment for COVID-19 caused by the SARS-CoV-2 coronavirus. Indeed, studies have shown that the replication of some RNA viruses, such as HIV-1 or cytomegalovirus, can be influenced by iron. Deferoxamine was able to inhibit viral replication in cells in vitro. For this reason, deferoxamine is being tested as part of the development of a treatment for COVID-19.

Search result : 6 product found

Refine your search :

RUOCE / IVD
  • Biochemicals 6
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
AG007ZDX-5g
 5g 
AG007ZDX-100mg
 100mg 
AG007ZDX-1g
 1g 
AG007ZDX-250mg
 250mg